Office of Technology Transfer-Resources for Industry - UC System-Wide Technology Transfer Forum on Stem Cell Research and Regenerative Medicine

UC System-Wide Technology Transfer Forum on Stem Cell Research and Regenerative Medicine

Hyatt Regency, Burlingame, CA
April 15, 2009

On April 15th, the University of California Office of Technology Transfer, in partnership with the British Consulate-General, San Francisco, and the Consulate General of Canada, San Francisco | Silicon Valley, hosted a forum on emerging research and business opportunities related to stem cells and regenerative medicine. This event brought the venture capital community and company representatives together with leading UC administrators and faculty and their British and Canadian counterparts to better understand how to work together to license inventions and form companies arising from university stem cell research. It featured speakers from UC campuses and British and Canadian institutions working in this area. Below you will find the presentations of the speakers and related information.

We hope you enjoyed this event and will participate in future forums.

Speeches & Panel Discussions

OPENING REMARKS
Steven V.W. Beckwith
Vice President, Research and Graduate Studies
University of California Office of the President

Marc LePage
Consul General of Canada

Stephan Winkler
Life Science Industry Lead Specialist for North America
UK Trade & Investment, British Consulate-General Boston

MORNING PANEL DISCUSSION
"Stem Cells & Regenerative Medicine: Successes and Challenges (pdf)"
Panelists:

Gregory Bonfiglio (Moderator): Founder and Managing General Partner, Proteus Venture Partners
Jane Lebkowski: Senior Vice President of Regenerative Medicine, Geron
Patricia Olson: Director, Scientific Activities, California Institute for Regenerative Medicine
Paul Kemp: Founder, Chief Scientific Officer and Executive Director, Intercytex, UK
Frank Gleeson: CEO, Verio Therapeutics, Canada

LUNCH-TIME PANEL DISCUSSION
"Bridging the Financing Gap in Stem Cell and Regenerative Medicine Commercialization"
Panelists:

Matthew Gardner (Moderator): President, BayBio
Jim McLoughlin: Executive Director, Pfizer Worldwide Business Development, Pfizer Biotherapeutics and Bioinnovations Center
Alan Trounson: President, California Institute for Regenerative Medicine
Martin Godbout: President and CEO, Genome Canada
Gregory Bonfiglio: Founder & Managing General Partner, Proteus Venture Partners
Fergus McKenzie: Programme Manager, ITI Life Sciences, UK

AFTERNOON PANEL DISCUSSION
“The Promise of Stem Cell Research and Regenerative Medicine (pdf)”
Panelists:

Marc LePage (Moderator): Consul General of Canada
Michael Rudnicki: Scientific Director, Stem Cell Network, Canada
George De Sanctis: Director, Partnership & Innovation, Sanofi-Aventis
Stefan Przyborski: Director & CSO, ReInnervate Limited, UK
Darin J. Weber: Senior Consultant, Biologics Consulting Group, Inc.

Presentations at Breakout Sessions
Session 1

Maria Pallavicini
Dean of Natural Sciences
University of California, Merced
"Understanding Stem Cell Fate Decisions: Novel New Technologies and Approaches"
William Stanford
Associate Professor, Institute of Biomaterials & Biomedical Engineering
University of Toronto, Ontario, Canada
"The Molecular Networks That Control Stem Cell Function or Lead to Disease"
Joanne Mountford
Senior Lecturer in Stem Cell Technology
ITI LifeSciences Stem Cell Lab
Faculty of Biomedical & Life Sciences
University of Glasgow, United Kingdom
"High Content Screening for Small Molecules that Modulate Behaviour of hESCs" (pdf)

Session 2

Alice F. Tarantal
Vice-Chair for Research, Dept. of Pediatrics, School of Medicine
Associate Director, Stem Cell Program, California National Primate Center
University of California, Davis
"Translational Studies for Stem/Progenitor Cell Research"
Duncan Stewart
CEO & Scientific Director; Sr. Scientist, Regenerative Medicine Program
Evelyne and Rowell Laishley Chair, Ottawa Health Research Institute
Vice-President, Research, The Ottawa Hospital
Professor, Department of Medicine, University of Ottawa, Canada
"Enhanced Cell Therapy for Cardiovascular Diseases" (pdf)
Harry Moore
Chair in Reproductive Biology
Center for Stem Cell Biology
University of Sheffield, United Kingdom
"Developing Stem Cell Technologies for Regenerative Stents and Other Therapeutic Applications"

Session 3

Brian J. Cummings
Assistant Professor, Department of Physical Medicine & Rehabilitation
Sue and Bill Gross Stem Cell Center, Reeve-Irvine Research Center
University of California, Irvine
"Immunosuppressant Directed Differentiation of Human Neural Stem Cells and Treatment of Spinal Cord Injury"
Freda Miller
Professor, Department of Physiology
Canada Research Chair in Developmental Neurobiology
University of Toronto, Ontario, Canada
"SKPs: From Dermis to Nerve and Back Again"
Jeffrey C. Lotz
Professor, Orthopaedic Surgery; Director, Orthopaedic Bioengineering Lab
Vice-Chair, UCSF Program in Bioengineering
University of California, San Francisco
"Guiding Stem Cells to Treat Back Pain" (pdf)

Session 4

David Schaffer
Professor, Chemical Engineering, Bioengineering & The Helen Wills Neuroscience Institute
Associate Director, Berkeley Stem Cell Center
University of California, Berkeley
"Engineering Bioactive Materials to Study and Control Stem Cell Function" (pdf)
Andras Nagy
Sr. Scientist, Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Professor, Department of Molecular Genetics
University of Toronto, Ontario, Canada
"Novel Non-Viral Approaches for Safe iPS Cell Derivation" (pdf)
Michael Whitaker
Co-Director of North East England Stem Cell Institute
Universities of Durham and Newcastle, United Kingdom
"An Overview of Technology Transfer and Translational Stem Cell Research in North-East England" (pdf)

AFTERNOON BREAKOUT SESSIONS

Session 1

Nicole I. Zur Nieden
Assistant Professor, Dept. of Cell Biology & Neuroscience
University of California, Riverside
"Bioreactor Cultures for the Large-Scale Expansion and Computer-Controlled Growth of ESCs-Applications in Cell Therapy and Pharmacological Screening"
Fabio Rossi
Assistant Professor, Canada Research Chair in Regenerative Medicine
Biomedical Research Centre
University of British Columbia, BC, Canada
"Isolation, Characterization and Therapeutic Potential of Fibro/Adipogenic Progenitors"
Julian Chaudhuri
Professor, Biochemical & Biomedical Engineering
Head, Department of Chemical Engineering
Deputy Director, Center for Regenerative Medicine
University of Bath, United Kingdom
"Bioreactors for Stem Cell Culture and Regenerative Medicine"

Session 2

Jan A. Nolta
Professor, Hematology and Oncology, Department of Medicine
Director, Stem Cell Program
University of California, Davis
"Novel Stem Cell Therapeutics for Neurodegenerative Diseases"
Michael Rudnicki
Professor, Department of Medicine
Senior Scientist and Director of Regenerative Medicine Program
Director, Sprott Centre for Stem Cell Research
Ottawa Health Research Institute, Canada
"Muscle Stem Cells"
Richard Oreffo
Chair in Musculoskeletal Science & Associate Dean (Innovation & Enterprise)
Faculty of Medicine, Bone & Joint Research Group
Centre for Human Development, Stem Cells and Regeneration
University of Southampton, United Kingdom
"Bone Regeneration"

Session 3

Ken Cho
Professor and Department Chair, Developmental & Cell Biology
University of California, Irvine
"A Perfusion Bioreactor for Large Scale Production of Uniformly Differentiated Cells From ES Cells"
Tim Kieffer
Professor, Department of Cellular and Physiological Sciences, and Surgery
University of British Columbia, BC, Canada
"Targeting Gut Stem cells to Treat Diabetes"
Paul De Sousa
Senior Research Fellow
Director, The Roslin Cells Center
MRC Centre for Regenerative Medicine
University of Edinburgh, United Kingdom
"Evolving the Biosafety of Pluripotent Cell Therapies" (pdf)

Session 4

Bin Chen
Assistant Professor, Molecular, Cell & Developmental Biology
University of California, Santa Cruz
"Wiring up the Brain: How Transcription Factors Regulate Neural Stem Cell Differentiation"
David Kaplan
Sr. Scientist and Head, Cancer Research; The Hospital for Sick Children
Professor, Department of Molecular Genetics
University of Toronto, Ontario, Canada
"Signalling Protein and Drug Discovery Using Cancer Stem Cells"
Noboru Sato
Assistant Professor, Dept. of Biochemistry
University of California, Riverside
"New Methods to Culture hESC and iPS in a Fully Defined Environment"

Additional Information

For more information about this forum or future conferences, please contact Gonzalo Barrera-Hernandez at 510-587-6014 or by email at:
Gonzalo.Barrera-Hernandez@ucop.edu.

Previous System-Wide Technology Transfer Forums

Clean Technology (April, 2008)
Nanotechnology (April, 2007)
Cardiovascular Disease (May, 2006)
Cancer Initiatives at UC (November, 2005)
Inaugural Technology Transfer Forum (April, 2005)

Survey
If you didn't have a chance to fill out your survey, please take a few moments to let us know what you thought of the forum, and what kinds of conferences you would like to see in the future. Click here to take the survey.

Back UC System-Wide Technology Transfer Forum home page.


	Disclosing an Invention Working with Industry Research Materials IP for the Researcher Working with UC Available Technologies Strawberry Licensing Events for Industry UC Contacts Staff Information & Guidance Operational Tools Ask OTT Material Transfers Staff Events Educational Materials Tech Transfer Program UC TT Policies & Guidance Available Technologies Annual Reports Additional Resources/Links
About OTT UC Contacts Home Resources for Industry Working with UC Available Technologies Strawberry Licensing Events for Industry UC Contacts For inquiries or suggestions for this web site email
	UC System-Wide Technology Transfer Forum on Stem Cell Research and Regenerative Medicine Hyatt Regency, Burlingame, CA April 15, 2009 On April 15th, the University of California Office of Technology Transfer, in partnership with the British Consulate-General, San Francisco, and the Consulate General of Canada, San Francisco \| Silicon Valley, hosted a forum on emerging research and business opportunities related to stem cells and regenerative medicine. This event brought the venture capital community and company representatives together with leading UC administrators and faculty and their British and Canadian counterparts to better understand how to work together to license inventions and form companies arising from university stem cell research. It featured speakers from UC campuses and British and Canadian institutions working in this area. Below you will find the presentations of the speakers and related information. We hope you enjoyed this event and will participate in future forums. Agenda (pdf) Announcement (pdf) Attendees (pdf) Sponsors (pdf) Partners(pdf) Speeches & Panel Discussions OPENING REMARKS Steven V.W. Beckwith Vice President, Research and Graduate Studies University of California Office of the President Marc LePage Consul General of Canada Stephan Winkler Life Science Industry Lead Specialist for North America UK Trade & Investment, British Consulate-General Boston MORNING PANEL DISCUSSION "Stem Cells & Regenerative Medicine: Successes and Challenges (pdf)" Panelists: Gregory Bonfiglio (Moderator): Founder and Managing General Partner, Proteus Venture Partners Jane Lebkowski: Senior Vice President of Regenerative Medicine, Geron Patricia Olson: Director, Scientific Activities, California Institute for Regenerative Medicine Paul Kemp: Founder, Chief Scientific Officer and Executive Director, Intercytex, UK Frank Gleeson: CEO, Verio Therapeutics, Canada LUNCH-TIME PANEL DISCUSSION "Bridging the Financing Gap in Stem Cell and Regenerative Medicine Commercialization" Panelists: Matthew Gardner (Moderator): President, BayBio Jim McLoughlin: Executive Director, Pfizer Worldwide Business Development, Pfizer Biotherapeutics and Bioinnovations Center Alan Trounson: President, California Institute for Regenerative Medicine Martin Godbout: President and CEO, Genome Canada Gregory Bonfiglio: Founder & Managing General Partner, Proteus Venture Partners Fergus McKenzie: Programme Manager, ITI Life Sciences, UK AFTERNOON PANEL DISCUSSION “The Promise of Stem Cell Research and Regenerative Medicine (pdf)” Panelists: Marc LePage (Moderator): Consul General of Canada Michael Rudnicki: Scientific Director, Stem Cell Network, Canada George De Sanctis: Director, Partnership & Innovation, Sanofi-Aventis Stefan Przyborski: Director & CSO, ReInnervate Limited, UK Darin J. Weber: Senior Consultant, Biologics Consulting Group, Inc. Presentations at Breakout Sessions Session 1 Maria Pallavicini Dean of Natural Sciences University of California, Merced "Understanding Stem Cell Fate Decisions: Novel New Technologies and Approaches" William Stanford Associate Professor, Institute of Biomaterials & Biomedical Engineering University of Toronto, Ontario, Canada "The Molecular Networks That Control Stem Cell Function or Lead to Disease" Joanne Mountford Senior Lecturer in Stem Cell Technology ITI LifeSciences Stem Cell Lab Faculty of Biomedical & Life Sciences University of Glasgow, United Kingdom "High Content Screening for Small Molecules that Modulate Behaviour of hESCs" (pdf) Session 2 Alice F. Tarantal Vice-Chair for Research, Dept. of Pediatrics, School of Medicine Associate Director, Stem Cell Program, California National Primate Center University of California, Davis "Translational Studies for Stem/Progenitor Cell Research" Duncan Stewart CEO & Scientific Director; Sr. Scientist, Regenerative Medicine Program Evelyne and Rowell Laishley Chair, Ottawa Health Research Institute Vice-President, Research, The Ottawa Hospital Professor, Department of Medicine, University of Ottawa, Canada "Enhanced Cell Therapy for Cardiovascular Diseases" (pdf) Harry Moore Chair in Reproductive Biology Center for Stem Cell Biology University of Sheffield, United Kingdom "Developing Stem Cell Technologies for Regenerative Stents and Other Therapeutic Applications" Session 3 Brian J. Cummings Assistant Professor, Department of Physical Medicine & Rehabilitation Sue and Bill Gross Stem Cell Center, Reeve-Irvine Research Center University of California, Irvine "Immunosuppressant Directed Differentiation of Human Neural Stem Cells and Treatment of Spinal Cord Injury" Freda Miller Professor, Department of Physiology Canada Research Chair in Developmental Neurobiology University of Toronto, Ontario, Canada "SKPs: From Dermis to Nerve and Back Again" Jeffrey C. Lotz Professor, Orthopaedic Surgery; Director, Orthopaedic Bioengineering Lab Vice-Chair, UCSF Program in Bioengineering University of California, San Francisco "Guiding Stem Cells to Treat Back Pain" (pdf) Session 4 David Schaffer Professor, Chemical Engineering, Bioengineering & The Helen Wills Neuroscience Institute Associate Director, Berkeley Stem Cell Center University of California, Berkeley "Engineering Bioactive Materials to Study and Control Stem Cell Function" (pdf) Andras Nagy Sr. Scientist, Samuel Lunenfeld Research Institute, Mount Sinai Hospital Professor, Department of Molecular Genetics University of Toronto, Ontario, Canada "Novel Non-Viral Approaches for Safe iPS Cell Derivation" (pdf) Michael Whitaker Co-Director of North East England Stem Cell Institute Universities of Durham and Newcastle, United Kingdom "An Overview of Technology Transfer and Translational Stem Cell Research in North-East England" (pdf) AFTERNOON BREAKOUT SESSIONS Session 1 Nicole I. Zur Nieden Assistant Professor, Dept. of Cell Biology & Neuroscience University of California, Riverside "Bioreactor Cultures for the Large-Scale Expansion and Computer-Controlled Growth of ESCs-Applications in Cell Therapy and Pharmacological Screening" Fabio Rossi Assistant Professor, Canada Research Chair in Regenerative Medicine Biomedical Research Centre University of British Columbia, BC, Canada "Isolation, Characterization and Therapeutic Potential of Fibro/Adipogenic Progenitors" Julian Chaudhuri Professor, Biochemical & Biomedical Engineering Head, Department of Chemical Engineering Deputy Director, Center for Regenerative Medicine University of Bath, United Kingdom "Bioreactors for Stem Cell Culture and Regenerative Medicine" Session 2 Jan A. Nolta Professor, Hematology and Oncology, Department of Medicine Director, Stem Cell Program University of California, Davis "Novel Stem Cell Therapeutics for Neurodegenerative Diseases" Michael Rudnicki Professor, Department of Medicine Senior Scientist and Director of Regenerative Medicine Program Director, Sprott Centre for Stem Cell Research Ottawa Health Research Institute, Canada "Muscle Stem Cells" Richard Oreffo Chair in Musculoskeletal Science & Associate Dean (Innovation & Enterprise) Faculty of Medicine, Bone & Joint Research Group Centre for Human Development, Stem Cells and Regeneration University of Southampton, United Kingdom "Bone Regeneration" Session 3 Ken Cho Professor and Department Chair, Developmental & Cell Biology University of California, Irvine "A Perfusion Bioreactor for Large Scale Production of Uniformly Differentiated Cells From ES Cells" Tim Kieffer Professor, Department of Cellular and Physiological Sciences, and Surgery University of British Columbia, BC, Canada "Targeting Gut Stem cells to Treat Diabetes" Paul De Sousa Senior Research Fellow Director, The Roslin Cells Center MRC Centre for Regenerative Medicine University of Edinburgh, United Kingdom "Evolving the Biosafety of Pluripotent Cell Therapies" (pdf) Session 4 Bin Chen Assistant Professor, Molecular, Cell & Developmental Biology University of California, Santa Cruz "Wiring up the Brain: How Transcription Factors Regulate Neural Stem Cell Differentiation" David Kaplan Sr. Scientist and Head, Cancer Research; The Hospital for Sick Children Professor, Department of Molecular Genetics University of Toronto, Ontario, Canada "Signalling Protein and Drug Discovery Using Cancer Stem Cells" Noboru Sato Assistant Professor, Dept. of Biochemistry University of California, Riverside "New Methods to Culture hESC and iPS in a Fully Defined Environment" Additional Information UC Available Technologies UC Resources for Industry UC Office of Technology Transfer 2008 Annual Report (pdf) For more information about this forum or future conferences, please contact Gonzalo Barrera-Hernandez at 510-587-6014 or by email at: Gonzalo.Barrera-Hernandez@ucop.edu. Previous System-Wide Technology Transfer Forums Clean Technology (April, 2008) Nanotechnology (April, 2007) Cardiovascular Disease (May, 2006) Cancer Initiatives at UC (November, 2005) Inaugural Technology Transfer Forum (April, 2005) Survey If you didn't have a chance to fill out your survey, please take a few moments to let us know what you thought of the forum, and what kinds of conferences you would like to see in the future. Click here to take the survey. Back UC System-Wide Technology Transfer Forum home page.